Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery
NCT ID: NCT06769100
Last Updated: 2025-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
48 participants
INTERVENTIONAL
2025-01-10
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Determining whether this maximally stimulated MPS response can be further heightened during post-exercise recovery using non-protein dietary factors is yet to be explored. Recently, it has been shown that novel orally ingested ketone body supplements can stimulate MPS rates in younger adults at rest.
Ketone bodies (β-OHB) are lipid- derived molecules normally produced under conditions of glucose deprivation (i.e., fasting/starvation, or a low carbohydrate 'ketogenic' diet). However, these orally ingested ketone supplements rapidly increase blood ketone levels without the need for dietary restriction6. In vitro research showed that the combination of leucine and ketone bodies stimulated a 2-fold increase in MPS, compared to the leucine group alone, indicating synergistic effects of protein and ketone bodies on MPS. However, the effect of ketone supplementation, with and without dietary protein co-ingestion, on MPS rate during post-exercise recovery is yet to be investigated. If ketone bodies can amplify the anabolic response to dietary protein, they may provide a novel approach to maximizing muscle adaptation during post-exercise recovery.
Therefore, the purpose of this study is to evaluate the effects of ketone monoester intake on postprandial muscle protein synthesis rates when consumed alone and when co-ingested with an optimal dose (25 g) of whey protein during recovery after resistance exercise compared to 1) an optimal dose of whey protein (25 g), and 2) a control flavored water. It is hypothesized that muscle protein synthesis rates will be stimulated following the ingestion of the ketone body beverage. Further, muscle protein synthesis rates will be further enhanced when the ketone-containing beverage and an optimal dose are taken together.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketones and Muscle Protein Synthesis
NCT04565444
The Effect of Ketone Monoesters on Skeletal Muscle Protein Synthesis and Whole-body Protein Metabolism.
NCT07082309
Post-exercise Dietary Protein Strategies
NCT01319513
The Effects Potato Protein on Rates of Myofibrillar Muscle Protein Synthesis in Young Women
NCT04302038
The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise.
NCT02980900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will include a screening visit (visit 1), 10-repetition maximum (10-RM) testing (visit 2), where participants' 10-RM will be determined for the exercise protocol, and the experimental trial (visit 3).
During the experimental trials, participants will arrive to the laboratory in a fasted state, and a prime dose of the L-\[ring-2H5\]-phenylalanine will be administered followed by a continuous infusion at a rate 0.05 μmol/kg of body weight/min. Then, participants will perform a unilateral lower-body resistance exercise, consisting of 8 sets of 10 reps of unilateral leg extension at 90% of their 10-RM with 90 seconds rest in between sets. Following exercise, the nutritional treatment will be administered.
Arterialized blood will be collected at baseline and 13 postprandial timepoints across 9 hours for plasma amino acid, glucose, and insulin quantitation.
Additionally, changes in capillary blood β-HB concentration will be assessed throughout the trial by collecting capillary blood samples at baseline and 10 postprandial timepoints. Finally, muscle biopsy samples from both the exercised leg and the rested leg will be collected prior to beverage intake and at the 5-hour mark of the postprandial post-recovery period to assess myofibrillar protein synthesis rates.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketone Monoester (KET)
Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight).
Ketone Monoester (KET)
\- Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester
Resistance exercise
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Ketone Monoester + Whey Protein (KET+PRO)
Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) and 25g of whey protein.
Ketone Monoester + Whey Protein (KET+PRO)
* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight)
* 25g Whey Protein
* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Resistance exercise
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Whey Protein (PRO)
25g of whey protein.
Whey Protein (PRO)
* 25g Whey Protein
* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Resistance exercise
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Placebo drink (CON)
Flavoured water.
Flavour matched placebo (CON)
\- Flavoured water (non-caloric bitter + citrus flavours)
Resistance exercise
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketone Monoester (KET)
\- Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester
Ketone Monoester + Whey Protein (KET+PRO)
* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight)
* 25g Whey Protein
* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Whey Protein (PRO)
* 25g Whey Protein
* L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)
Flavour matched placebo (CON)
\- Flavoured water (non-caloric bitter + citrus flavours)
Resistance exercise
\- 8 sets of 10 reps at 90% of 10- repetition maximum (10-RM) of unilateral leg extension with 90 seconds rest in between sets.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderately active (i.e., ≥ 1 session of lower-body weightlifting /week for the previous 2 months).
Exclusion Criteria
* Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
* Females who are lactating or pregnant
* Females using third-generation oral contraceptives (including: Desogen®, Ortho-Cept, Ortho-Cyclen, Ortho Tri-Cyclen) as these are known to affect protein metabolism in females.
* Individuals with metabolic disorders including: Type I or Type II diabetes
* Individuals with a history of thrombosis / cardiovascular disease
* Individuals who use of anticoagulants
* Individuals with musculoskeletal / orthopedic disorders
* Individuals with knee injuries (i.e., ACL injuries).
* Individuals who have used tobacco products within the last 6 months
* Individuals with a history of neuromuscular problems
* Chronic usage of medications known to modulate skeletal muscle metabolism (i.e. corticosteroids, hormone replacement therapy (HRT), and over-the-counter supplements including creatine monohydrate) in the last 6 months.
* Individuals with allergies to milk proteins (whey or casein).
* Individuals with lactose intolerance
* Individuals with Phenylketonuria (PKU)
* Previous participation in amino acid tracer studies.
* Adherence to a vegetarian or vegan diet
* Current use of ketone supplements or adherence to a ketogenic diet
* Individuals who train more than ≥ 5 sessions of lower-body weightlifting /week for the previous 4 months
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tyler Churchward-Venne
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tyler Churchward-Venne, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Kinesiology and Physical Education, McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill University
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tyler Churchward-Venne, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A00-M15-24A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.